Dr Judy Chou (AltruBio Inc)2024-11-07T10:00:19
Therapeutic antibodies play a key role in addressing unmet medical needs. Here, Dr Judy Chou, CEO, President and Board Member of AltruBio, Inc, explains how agonist antibodies show potential as a novel therapeutic approach in immunological diseases, helping to mediate interactions between circulating immune cells and influencing the intensity and ...
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-10T13:56:00Z
2024-01-10T08:23:16
Sponsored by BellBrook Labs
2023-01-19T15:38:17
Sponsored by Cell Signaling Technology
2026-06-04T07:05:00
Author Graham Craig
2024-02-01T11:52:50
Sponsored by Leica Microsystems
2023-01-06T10:25:33
Sponsored by Leica Microsystems
2024-02-08T11:07:39
Sponsored by Samplix ApS
Site powered by Webvision Cloud